Skip to main navigation
Skip to search
Skip to main content
UT MD Anderson Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at UT MD Anderson Cancer Center
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Targeted Drug Therapy in Pancreatic Cancer
Don Lynn Gibbons
,
Robert A. Wolff
, Gauri R Varadhachary
Thoracic Head & Neck Medical Oncology
GI Medical Oncology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeted Drug Therapy in Pancreatic Cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pancreatic Cancer
100%
Targeted Drug Therapy
100%
Solid Tumors
25%
Tumor Subtype
25%
Cancer Patients
25%
Overall Survival
25%
Targeted Therapy
25%
Trial Design
25%
Metastasizing
25%
Cytotoxic Chemotherapy
25%
Difficult-to-treat
25%
Biologic Characteristics
25%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Cancer
100%
Pharmacotherapy
100%
Solid Malignant Neoplasm
25%
Overall Survival
25%
Cytotoxic Chemotherapy
25%